103 related articles for article (PubMed ID: 2753126)
1. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer.
Nakagawa Y; Otsuki T; Coe FL
FEBS Lett; 1989 Jul; 250(2):187-90. PubMed ID: 2753126
[TBL] [Abstract][Full Text] [Related]
2. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
[TBL] [Abstract][Full Text] [Related]
3. Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.
Nakagawa Y
Keio J Med; 1997 Mar; 46(1):1-9. PubMed ID: 9095576
[TBL] [Abstract][Full Text] [Related]
4. Nephrocalcin in patients with renal cell carcinoma.
Nakagawa Y; Netzer M; Michaels EK; Suzuki F; Ito H
J Urol; 1994 Jul; 152(1):29-34. PubMed ID: 8201680
[TBL] [Abstract][Full Text] [Related]
5. Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.
Deganello S
Calcif Tissue Int; 1991 Jun; 48(6):421-8. PubMed ID: 2070277
[TBL] [Abstract][Full Text] [Related]
6. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine.
Nakagawa Y; Abram V; Coe FL
Am J Physiol; 1984 Nov; 247(5 Pt 2):F765-72. PubMed ID: 6496744
[TBL] [Abstract][Full Text] [Related]
7. Protein inhibitors of crystal growth.
Kaiser ET; Bock SC
J Urol; 1989 Mar; 141(3 Pt 2):750-2. PubMed ID: 2645434
[TBL] [Abstract][Full Text] [Related]
8. Isolation of nephrocalcin from kidney tissue of nine vertebrate species.
Nakagawa Y; Renz CL; Ahmed M; Coe FL
Am J Physiol; 1991 Feb; 260(2 Pt 2):F243-8. PubMed ID: 1996674
[TBL] [Abstract][Full Text] [Related]
9. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo.
Nakagawa Y; Sirivongs D; Novy MB; Netzer MF; Michaels E; Vogelzang NJ; Coe FL
Cancer Res; 1992 Mar; 52(6):1573-9. PubMed ID: 1540966
[TBL] [Abstract][Full Text] [Related]
10. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
Asplin J; DeGanello S; Nakagawa YN; Coe FL
Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713
[TBL] [Abstract][Full Text] [Related]
11. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
Thongboonkerd V; Chutipongtanate S; Semangoen T; Malasit P
J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibitor of calcium oxalate monohydrate crystal in vitamin B6-deficient rat urine and kidney.
Tsubouchi R; Takeuchi F; Shibata Y
J Nutr Sci Vitaminol (Tokyo); 1988 Feb; 34(1):79-84. PubMed ID: 3392610
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.
Nakagawa Y; Abram V; Kézdy FJ; Kaiser ET; Coe FL
J Biol Chem; 1983 Oct; 258(20):12594-600. PubMed ID: 6630201
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
Hess B; Nakagawa Y; Coe FL
Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
[TBL] [Abstract][Full Text] [Related]
15. Evidence that mouse renal proximal tubule cells produce nephrocalcin.
Sirivongs D; Nakagawa Y; Vishny WK; Favus MJ; Coe FL
Am J Physiol; 1989 Sep; 257(3 Pt 2):F390-8. PubMed ID: 2782421
[TBL] [Abstract][Full Text] [Related]
16. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
Coe FL; Nakagawa Y; Asplin J; Parks JH
Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
[TBL] [Abstract][Full Text] [Related]
17. Characterization of calcium-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin with vanadyl ions: electron paramagnetic resonance and electron nuclear double resonance spectroscopy.
Mustafi D; Nakagawa Y
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11323-7. PubMed ID: 7972057
[TBL] [Abstract][Full Text] [Related]
18. The reappraisal of nephrocalcin--its role in the inhibition of calcium oxalate crystal growth and interaction with divalent metal ions.
Chang LC; Lin HS; Chen WC
Urol Res; 2001 Apr; 29(2):89-93. PubMed ID: 11396734
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Ca(2+)-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR.
Mustafi D; Nakagawa Y
Biochemistry; 1996 Nov; 35(47):14703-9. PubMed ID: 8942630
[TBL] [Abstract][Full Text] [Related]
20. FKBP-12 exhibits an inhibitory activity on calcium oxalate crystal growth in vitro.
Han IS; Nakagawa Y; Park JW; Suh MH; Suh SI; Shin SW; Ahn SY; Choe BK
J Korean Med Sci; 2002 Feb; 17(1):41-8. PubMed ID: 11850587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
